Cogentus Pharmaceuticals Inc.

Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding.
Cancer Weekly; 8/25/2009; 1741 words; Constellation Pharmaceuticals, Inc., the leading biopharmaceutical...Constellation Pharmaceuticals, Inc.). Dr. Goldsmith has held...served as cofounder and CEO of Cogentus Pharmaceuticals, Inc. and Senior Vice President of...

Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding; Company Leading Emerging Field of Epigenetics.
M2 Presswire; 8/13/2009; 1436 words; ...August 2009-Constellation Pharmaceuticals: Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith...Constellation Pharmaceuticals, Inc., the leading biopharmaceutical...as cofounder and CEO of Cogentus Pharmaceuticals, Inc. and Senior Vice President...

European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals.
PR Newswire Europe; 6/16/2008; 956 words; ...patient base of the study." ABOUT COGENTUS Cogentus Pharmaceuticals, Inc., of Menlo Park, CA, is a privately held specialty pharmaceutical company founded in 2006. Cogentus (http://www.cogentus.net...

New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy.
Health & Medicine Week; 5/19/2008; 934 words; ...according to data released by Cogentus Pharmaceuticals, Inc. here today at the annual meeting...President for Clinical Strategy at Cogentus. "Inhibition of normal platelet...Treatment, Cogentus Pharmaceuticals Inc. This article was prepared...

Appointments And Advancements.
BIOWORLD Today; 3/5/2008; 1123 words; ...financial officer. Ceragenix Pharmaceuticals Inc., of Denver, named Michael...from the board. Clinical Data Inc., of Newton, Mass., appointed...which is a new position. Cogentus Pharmaceuticals Inc., of Menlo Park, Calif...